Cargando…
Clinical features and 28-day mortality predictors of vaccinated patients admitted to a COVID-19 ICU hub in Italy
BACKGROUND: COVID-19 vaccination has been proved to be effective in preventing hospitalization and illness progression, even though data on mortality of vaccinated patients in the intensive care unit (ICU) are conflicting. The aim of this study was to investigate the characteristics of vaccinated pa...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644635/ https://www.ncbi.nlm.nih.gov/pubmed/37957713 http://dx.doi.org/10.1186/s44158-023-00130-6 |
_version_ | 1785147271162101760 |
---|---|
author | Stella, Claudia Berardi, Cecilia Chiarito, Annalisa Gennenzi, Veronica Postorino, Stefania Settanni, Donatella Cesarano, Melania Xhemalaj, Rikardo Tanzarella, Eloisa Sofia Cutuli, Salvatore Lucio Grieco, Domenico Luca Conti, Giorgio Antonelli, Massimo De Pascale, Gennaro |
author_facet | Stella, Claudia Berardi, Cecilia Chiarito, Annalisa Gennenzi, Veronica Postorino, Stefania Settanni, Donatella Cesarano, Melania Xhemalaj, Rikardo Tanzarella, Eloisa Sofia Cutuli, Salvatore Lucio Grieco, Domenico Luca Conti, Giorgio Antonelli, Massimo De Pascale, Gennaro |
author_sort | Stella, Claudia |
collection | PubMed |
description | BACKGROUND: COVID-19 vaccination has been proved to be effective in preventing hospitalization and illness progression, even though data on mortality of vaccinated patients in the intensive care unit (ICU) are conflicting. The aim of this study was to investigate the characteristics of vaccinated patients admitted to ICU according to their immunization cycle and to outline the risk factors for 28-day mortality. This observational study included adult patients admitted to ICU for acute respiratory failure (ARF) due to SARS-CoV-2 and who had received at least one dose of vaccine. RESULTS: Fully vaccination was defined as a complete primary cycle from < 120 days or a booster dose from > 14 days. All the other patients were named partially vaccinated. One-hundred sixty patients (91 fully and 69 partially vaccinated) resulted eligible, showing a 28-day mortality rate of 51.9%. Compared to partially vaccinated, fully vaccinated were younger (69 [60–77.5] vs. 74 [66–79] years, p 0.029), more frequently immunocompromised (39.56% vs. 14.39%, p 0.003), and affected by at least one comorbidity (90.11% vs 78.26%, p 0.045), mainly chronic kidney disease (CKD) (36.26% vs 20.29%, p 0.035). At multivariable analysis, independent predictors of 28-day mortality were as follows: older age [OR 1.05 (CI 95% 1.01–1.08), p 0.005], history of chronic obstructive pulmonary disease (COPD) [OR 3.05 (CI 95% 1.28–7.30), p 0.012], immunosuppression [OR 3.70 (CI 95% 1.63–8.40), p 0.002], and admission respiratory and hemodynamic status [PaO(2)/FiO(2) and septic shock: OR 0.99 (CI 95% 0.98–0.99), p 0.009 and 2.74 (CI 95% 1.16–6.48), p 0.022, respectively]. CONCLUSIONS: Despite a full vaccination cycle, severe COVID-19 may occur in patients with relevant comorbidities, especially immunosuppression and CKD. Regardless the immunization status, predisposing conditions (i.e., older age, COPD, and immunosuppression) and a severe clinical presentation were predictors of 28-day mortality. |
format | Online Article Text |
id | pubmed-10644635 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-106446352023-11-13 Clinical features and 28-day mortality predictors of vaccinated patients admitted to a COVID-19 ICU hub in Italy Stella, Claudia Berardi, Cecilia Chiarito, Annalisa Gennenzi, Veronica Postorino, Stefania Settanni, Donatella Cesarano, Melania Xhemalaj, Rikardo Tanzarella, Eloisa Sofia Cutuli, Salvatore Lucio Grieco, Domenico Luca Conti, Giorgio Antonelli, Massimo De Pascale, Gennaro J Anesth Analg Crit Care Original Article BACKGROUND: COVID-19 vaccination has been proved to be effective in preventing hospitalization and illness progression, even though data on mortality of vaccinated patients in the intensive care unit (ICU) are conflicting. The aim of this study was to investigate the characteristics of vaccinated patients admitted to ICU according to their immunization cycle and to outline the risk factors for 28-day mortality. This observational study included adult patients admitted to ICU for acute respiratory failure (ARF) due to SARS-CoV-2 and who had received at least one dose of vaccine. RESULTS: Fully vaccination was defined as a complete primary cycle from < 120 days or a booster dose from > 14 days. All the other patients were named partially vaccinated. One-hundred sixty patients (91 fully and 69 partially vaccinated) resulted eligible, showing a 28-day mortality rate of 51.9%. Compared to partially vaccinated, fully vaccinated were younger (69 [60–77.5] vs. 74 [66–79] years, p 0.029), more frequently immunocompromised (39.56% vs. 14.39%, p 0.003), and affected by at least one comorbidity (90.11% vs 78.26%, p 0.045), mainly chronic kidney disease (CKD) (36.26% vs 20.29%, p 0.035). At multivariable analysis, independent predictors of 28-day mortality were as follows: older age [OR 1.05 (CI 95% 1.01–1.08), p 0.005], history of chronic obstructive pulmonary disease (COPD) [OR 3.05 (CI 95% 1.28–7.30), p 0.012], immunosuppression [OR 3.70 (CI 95% 1.63–8.40), p 0.002], and admission respiratory and hemodynamic status [PaO(2)/FiO(2) and septic shock: OR 0.99 (CI 95% 0.98–0.99), p 0.009 and 2.74 (CI 95% 1.16–6.48), p 0.022, respectively]. CONCLUSIONS: Despite a full vaccination cycle, severe COVID-19 may occur in patients with relevant comorbidities, especially immunosuppression and CKD. Regardless the immunization status, predisposing conditions (i.e., older age, COPD, and immunosuppression) and a severe clinical presentation were predictors of 28-day mortality. BioMed Central 2023-11-13 /pmc/articles/PMC10644635/ /pubmed/37957713 http://dx.doi.org/10.1186/s44158-023-00130-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Stella, Claudia Berardi, Cecilia Chiarito, Annalisa Gennenzi, Veronica Postorino, Stefania Settanni, Donatella Cesarano, Melania Xhemalaj, Rikardo Tanzarella, Eloisa Sofia Cutuli, Salvatore Lucio Grieco, Domenico Luca Conti, Giorgio Antonelli, Massimo De Pascale, Gennaro Clinical features and 28-day mortality predictors of vaccinated patients admitted to a COVID-19 ICU hub in Italy |
title | Clinical features and 28-day mortality predictors of vaccinated patients admitted to a COVID-19 ICU hub in Italy |
title_full | Clinical features and 28-day mortality predictors of vaccinated patients admitted to a COVID-19 ICU hub in Italy |
title_fullStr | Clinical features and 28-day mortality predictors of vaccinated patients admitted to a COVID-19 ICU hub in Italy |
title_full_unstemmed | Clinical features and 28-day mortality predictors of vaccinated patients admitted to a COVID-19 ICU hub in Italy |
title_short | Clinical features and 28-day mortality predictors of vaccinated patients admitted to a COVID-19 ICU hub in Italy |
title_sort | clinical features and 28-day mortality predictors of vaccinated patients admitted to a covid-19 icu hub in italy |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644635/ https://www.ncbi.nlm.nih.gov/pubmed/37957713 http://dx.doi.org/10.1186/s44158-023-00130-6 |
work_keys_str_mv | AT stellaclaudia clinicalfeaturesand28daymortalitypredictorsofvaccinatedpatientsadmittedtoacovid19icuhubinitaly AT berardicecilia clinicalfeaturesand28daymortalitypredictorsofvaccinatedpatientsadmittedtoacovid19icuhubinitaly AT chiaritoannalisa clinicalfeaturesand28daymortalitypredictorsofvaccinatedpatientsadmittedtoacovid19icuhubinitaly AT gennenziveronica clinicalfeaturesand28daymortalitypredictorsofvaccinatedpatientsadmittedtoacovid19icuhubinitaly AT postorinostefania clinicalfeaturesand28daymortalitypredictorsofvaccinatedpatientsadmittedtoacovid19icuhubinitaly AT settannidonatella clinicalfeaturesand28daymortalitypredictorsofvaccinatedpatientsadmittedtoacovid19icuhubinitaly AT cesaranomelania clinicalfeaturesand28daymortalitypredictorsofvaccinatedpatientsadmittedtoacovid19icuhubinitaly AT xhemalajrikardo clinicalfeaturesand28daymortalitypredictorsofvaccinatedpatientsadmittedtoacovid19icuhubinitaly AT tanzarellaeloisasofia clinicalfeaturesand28daymortalitypredictorsofvaccinatedpatientsadmittedtoacovid19icuhubinitaly AT cutulisalvatorelucio clinicalfeaturesand28daymortalitypredictorsofvaccinatedpatientsadmittedtoacovid19icuhubinitaly AT griecodomenicoluca clinicalfeaturesand28daymortalitypredictorsofvaccinatedpatientsadmittedtoacovid19icuhubinitaly AT contigiorgio clinicalfeaturesand28daymortalitypredictorsofvaccinatedpatientsadmittedtoacovid19icuhubinitaly AT antonellimassimo clinicalfeaturesand28daymortalitypredictorsofvaccinatedpatientsadmittedtoacovid19icuhubinitaly AT depascalegennaro clinicalfeaturesand28daymortalitypredictorsofvaccinatedpatientsadmittedtoacovid19icuhubinitaly |